Early life sugar rationing and ageing related diseases, biological ageing and mortality
Abstract
Early-life nutrition may influence lifelong ageing, yet human evidence is scarce. Using Britain’s postwar sugar rationing as a natural experiment, we examine its long-term effects in 64,809 United Kingdom Biobank participants. Exposure to sugar rationing during the first 1,000 days of life is associated with a 9% lower incidence of hallmark-related disease, with a hazard ratio of 0.91 and a 95% confidence interval of 0.88–0.94, and a 19% lower risk of all-cause mortality, with a hazard ratio of 0.81 and a 95% confidence interval of 0.69–0.93. Mediation analysis indicates that the survival association is statistically mediated, by approximately 60%, through differences in incident hallmark-related disease. Rationed individuals show 1.0–1.2-year younger biological ages across multiple clocks and lower organ ages, particularly in the lung, heart, and liver. Proteomic profiling identifies 47 altered proteins, with enrichment of adenosine monophosphate-activated protein kinase and longevity pathways and suppression of mechanistic target of rapamycin signaling. These findings are consistent with international recommendations to limit free or added sugars from the World Health Organization, United States Dietary Guidelines, and American Heart Association, and may inform policy discussions related to sugar taxation and infant food and marketing policies under the United Nations 2030 Agenda. Studies on how early-life nutrition influence ageing are limited. Here, using data from the UK Biobank, the authors find that sugar rationing during early life is associated with a lower incidence of ageing-related diseases and slower aging.
// Source
Authors: Jiazhen Zheng, Zhen Zhou, Jinghan Huang, Qiang Tu, Haisheng Wu, Quan Yang, Qi Qi, Wenbo Huang, Qingwen Ren, Junchun Shen, Xinlong Shi, Can Chen, Chuang Yang, Daniel J. Cuthbertson
Institutions: First Affiliated Hospital of Bengbu Medical College, University of Hong Kong, The University of Sydney, Brown University, University of Liverpool, Boston University, Friedrich-Alexander-Universität Erlangen-Nürnberg, Bioscience (China), Shenzhen University Health Science Center, Monash University, Chinese University of Hong Kong, University of Hong Kong - Shenzhen Hospital, University of Tokyo Health Sciences, Queen Mary Hospital, Universitätsklinikum Erlangen, Second Affiliated Hospital of Zhejiang University, Aintree University Hospitals NHS Foundation Trust, Merseytravel, Liverpool Womens NHS Foundation Trust